Jim Cramer Recently Answered Questions About These 10 Stocks
“We've had a huge wave of debt-fueled speculation that now threatens to wipe out your savings in a heartbeat.
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bourgeon Capital John Zaro | 23,547 | $17,966,134 | +83% | 3.24% |
| 2. | Ayrshire Capital Management John Nevin Jr. | 9,726 | $7,420,667 | +14% | 3.44% |
| 3. | Sivik Global Healthcare Krishen Sud | 10,000 | $7,630 | -10% | 2.22% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $691.79 | 715 | $494,626.99 | 14,685 | 2025-08-15 | Filing | |
| $660.25 | 758 | $500,472.53 | 758 | 2025-08-13 | Filing | |
| $647.36 | 1,000 | $647,360.00 | 20,562 | 2025-08-13 | Filing | |
| $644.77 | 1,632 | $1,052,263.01 | 546,601 | 2025-08-12 | Filing | |
| $634.41 | 1,000 | $634,405.00 | 137,660 | 2025-08-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $863.37 | 3,190 | $2,754,147.11 | 94,533,320 | 2025-10-10 | Filing | |
| $862.34 | 468 | $403,575.12 | 94,536,510 | 2025-10-10 | Filing | |
| $857.26 | 200 | $171,451.00 | 94,536,978 | 2025-10-09 | Filing | |
| $854.96 | 835 | $713,888.26 | 94,537,178 | 2025-10-09 | Filing | |
| $854.61 | 1,473 | $1,258,833.17 | 94,538,013 | 2025-10-09 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,553,263 | $1,185,139,669 | 1.2% | |
| 2. | 1,477,879 | $1,073,943,250 | 16.53% | |
| 3. | 815,807 | $622,460,741 | 0.9% | |
| 4. | 780,547 | $594,502,668 | 0.59% | |
| 5. | 690,583 | $525,483,694 | 0.85% |
News See All
Why is Eli Lilly and Company (LLY) One of the Best Long Term Low Volatility Stocks to Buy Right Now?
Eli Lilly and Company (NYSE:LLY) is one of the best long term low volatility stocks to buy right now. On October 17, J.P.
14 Best Long Term Low Volatility Stocks to Buy Right Now
Mike Wilson, Morgan Stanley CIO and chief U.S.
Eli Lilly and Company (LLY): A Bull Case Theory
We came across a bullish thesis on Eli Lilly and Company on Kontra Investments’s Substack by Kontra. In this article, we will summarize the bulls’ thesis on LLY.
Erste Group Upgrades Eli Lilly (LLY) to Buy Following Strong First-Half Results
Erste Group raised its rating on Eli Lilly and Company (NYSE:LLY) from Hold to Buy on October 13, citing the company’s strong performance during the first half of...
11 Defensive Healthcare Dividend Stocks To Buy Now
US healthcare stocks have been under mounting pressure this year, largely due to policies introduced by the Trump administration.
Eli Lilly Omvoh Demonstrates Sustained Long-Term Benefits in Ulcerative Colitis Up to Four Years
Eli Lilly and Company (NYSE:LLY) is one of the best growth stocks to buy now.
12 Best Growth Stocks to Buy Now
On October 1, Keith Lerner, Chief Investment Officer at Truist Wealth, appeared on CNBC and stated that the shutdown fears are muted, and investors are not overly concerned right now.
Guggenheim Reaffirms Its Buy Rating on Eli Lilly & Company (LLY) with Price Target of $875
The analyst noted that there was strong demand for tirzepatide in the treatment of diabetes and obesity and that the impending launch of orforglipron will support global growth.
Hedge Fund Resource Center Billionaire Hedge Funds
